Prevention of fetal movement during invasive procedures with pancuronium bromide.
The use of fetal intramuscular pancuronium (0.5 mg) to temporarily arrest fetal movement during antenatal intervention in six instances is reported. Successful arrest of movement without adverse side effects was observed. The use of this technique eliminates the need for the excessive and potentially dangerous maternal sedation currently used to minimize fetal movement.
D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000628:therapy; D005324:Fetal Movement / Q000187:drug effects*; D006801:Humans; D007273:Injections, Intramuscular; D010197:Pancuronium / Q000494:pharmacology*; D011247:Pregnancy
D010197:Pancuronium